U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.
The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug.
Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.
The growth potential of the weight-loss market could explode with advances, notably GLP-1 pills, and broader insurance ...
Those on Lilly’s pill outperformed the placebo on weight loss maintenance. Former Wegovy users on the pill regained just 2 ...